Bath & Body Works, Inc. filings document the public-company record for a Delaware specialty retailer whose common stock trades on the New York Stock Exchange under BBWI. Recent 8-K reports furnish quarterly and full-year operating results, earnings guidance, Regulation FD disclosures, debt redemption notices and executive officer changes.
Proxy materials describe board oversight, director elections, executive compensation, shareholder voting matters and governance practices tied to the company’s Consumer First Formula, brand, product, supply chain and store assets. The filings also identify registered common stock, senior notes disclosures and capital-structure matters for a personal care and home fragrance retail business.
Bath & Body Works, Inc. director Sarah E. Nash sold 0.692 shares of common stock on October 16, 2026, at $20.5650 per share. A footnote says the fractional shares were sold in conjunction with a transfer between her personal brokerage accounts. She directly held 299,101 shares after the transaction. No Rule 10b5-1 plan is reported.
Bath & Body Works, Inc. CEO and director Daniel Heaf acquired 591,366 performance rights in a one-time grant on September 21, 2026; his reported post-grant position was 591,366 rights. The units may be earned at 75%, 100%, 150% or 200% of target based on stock-price hurdles of $40, $60, $80 or $100, respectively, during a four-year performance period. The number earned is generally reduced by 50% if relative total shareholder return is below the 55th percentile of the S&P 1500 Consumer Discretionary Distribution & Retail Index. Earned units generally vest on the fourth anniversary, subject to continued employment.
Bath & Body Works, Inc. (BBWI) granted Chief Executive Officer Daniel Heaf a performance stock unit award with a $10 million target value, equal to 591,366 shares of common stock, on September 21, 2026. During the four-year performance period, an average closing price equal to or above $40, $60, $80 or $100 over any 60 consecutive trading days earns 75%, 100%, 150% or 200%, respectively, of the target number of PSUs.
Earned PSUs vest on the fourth anniversary of the grant date, generally subject to Mr. Heaf’s continued employment through that date or an earlier qualifying termination. The number otherwise earned is generally reduced by 50% if BBWI’s total shareholder return relative to companies in the S&P 1500 Consumer Discretionary Distribution & Retail Index is below the 55th percentile at the end of the four-year performance period.
Bath & Body Works, Inc. (BBWI) reported lower sales but sharply higher profitability for the quarter ended August 1, 2026. Net Sales were $1,514 million, down 2.3% year over year, as U.S. and Canada store sales fell 5.4% while Direct grew 3.0% and International and Other grew 24.9%.
Operating Income rose to $216 million from $157 million, and Net Income increased to $118 million from $64 million, helped by higher merchandise margins driven by about $80 million of IEEPA tariff refunds. Year-to-date, Net Income was $301 million versus $169 million, though adjusted Net Income was $190 million versus $183 million, reflecting sizeable one-time items including $88 million of interchange-fee settlements and a $62 million tax benefit.
Gross margin improved to 45.7% from 41.3%. Cash and cash equivalents were $794 million and total debt was $3,614 million, down from $3,892 million after a make-whole call of the 2027 notes. The company maintained its quarterly dividend of $0.20 per share and had $623 million of unused availability under its $750 million ABL facility.
Bath & Body Works, Inc. (BBWI) reported second quarter 2026 results with net sales of $1.514 billion, down 2.3% from $1.549 billion a year earlier, but earnings improved significantly. Earnings per diluted share rose to $0.58 from $0.30, and adjusted EPS increased to $0.62 from $0.37. Operating income grew to $216 million from $157 million, or $225 million on an adjusted basis. Results included about $80 million of tariff refunds, which the company estimates would have reduced adjusted EPS to $0.31 without this benefit. Year-to-date net cash provided by operating activities increased to $316 million from $145 million.
The company raised full-year 2026 EPS guidance to $3.13–$3.33 and set adjusted EPS guidance at $2.60–$2.80, compared with 2025 adjusted EPS of $3.21, while narrowing net sales guidance to a 4% to 2.5% decline versus 2025 sales of $7.291 billion. Free cash flow for 2026 is forecast at approximately $650 million. For the third quarter 2026, BBWI projects net sales to decline 5% to 2.5% with EPS of $0.05–$0.10 and adjusted EPS of $0.07–$0.12, both below the prior-year quarter.
Aber Ann reported acquisition or exercise transactions in this Form 4 filing.
Bath & Body Works, Inc. reported that Chief Legal Officer and Corporate Secretary Ann Aber received a new hire grant of 12,940 shares of common stock in the form of restricted stock units. The award vests 30% on the first and second anniversaries of the August 10, 2026 Grant Date, and 40% on the third anniversary, and represents her reported direct holding of 12,940 shares after the grant.
AQR Capital Management, LLC and its parent AQR Capital Management Holdings, LLC report amended passive ownership of Bath & Body Works, Inc. common stock. They beneficially own 7,641,815 shares, representing 3.79% of the outstanding common stock, which is ownership of 5 percent or less of the class. Both entities report shared voting power over 7,604,144 shares and shared dispositive power over 7,641,815 shares, with no sole voting or dispositive power. AQR Capital Management, LLC is a wholly owned subsidiary of AQR Capital Management Holdings, LLC, and the filing is signed by authorized signatory Henry Parkin.
Bath & Body Works, Inc. identifies officer Ann Aber, its Chief Legal Officer & Corporate Secretary, as a reporting insider through a beneficial ownership statement. The data shows no reportable transactions and no securities holdings entries for her in this filing.
Bath & Body Works, Inc. plans a partial redemption of $250 million aggregate principal amount of its outstanding 7.500% Senior Notes due 2029. The company issued a notice of partial redemption on July 20, 2026.
The redemption date will be August 19, 2026. The redemption price will equal 101.250% of the principal amount of the notes being redeemed, plus accrued interest to, but excluding, the redemption date. The company states that this disclosure does not itself constitute a notice of redemption.
Voskuil Steven E reported acquisition or exercise transactions in this Form 4 filing.
Bath & Body Works director Steven E. Voskuil received an equity grant as part of his board compensation. On June 11, 2026, he was awarded 7,970 shares of Common Stock, reported at a price of $0.00 per share, reflecting a compensation-related award rather than a market purchase. Following this grant, his direct holdings increased to 41,895 shares of Bath & Body Works common stock. A footnote describes this as an annual award of restricted stock units to independent non-employee directors, indicating it is a routine element of the company’s director compensation program.